VDAC1-interacting proteins: binding site mapping and their derived peptides induce apoptosis and multifaceted

Manikandan Santhanam1, Venkatadri Babu1, Anna Shteinfer-Kuzmine2

  • 1Department of Life Sciences, Ben-Gurion University of the Negev, 84105, Beer-Sheva, Israel.

Insights

Researchers identified specific binding sites on VDAC1-interacting proteins. Peptides derived from these sites can modulate VDAC1 activity, impacting cell death and signaling pathways for potential therapeutic applications.

Area of Science:

  • Molecular Biology and Mitochondrial Physiology
  • Biochemical investigation of VDAC1 binding site mapping
  • Pharmacological development of cell-penetrating peptides

Background:

Mitochondrial Voltage-Dependent Anion Channel-1 (VDAC1) serves as a fundamental gatekeeper for metabolic flux and apoptotic signaling across the outer mitochondrial membrane. Prior research has shown that this pore-forming protein interacts with over 100 distinct partners located within the cytosol, endoplasmic reticulum, plasma membrane, and various mitochondrial compartments. These complex associations allow the organelle to integrate diverse signals related to energy production, signal transduction, and programmed cell death. The coordination of these interactions is vital for maintaining cellular homeostasis and responding to physiological shifts in metabolic demand. While the breadth of the VDAC1 interactome is documented, the precise structural domains facilitating these protein-protein contacts remain largely uncharacterized. Understanding these specific contact points is essential for deciphering how mitochondria coordinate systemic cellular responses to stress. This absence of evidence motivated the current investigation into the molecular topography of these interaction sites.

Purpose Of The Study:

This investigation identifies the specific amino acid sequences on 19 different partner proteins that facilitate binding to the Voltage-Dependent Anion Channel-1 (VDAC1) scaffold. The researchers sought to map the interaction landscape by screening a vast library of potential binding motifs derived from known cytosolic and mitochondrial regulators. A primary objective involved determining if synthetic versions of these sequences could mimic the regulatory effects of the full-length parent proteins. The team specifically examined how these derived fragments influence mitochondrial homeostasis, calcium dynamics, and reactive oxygen species generation. They also aimed to evaluate the potential of these sequences to serve as therapeutic agents by inducing targeted apoptosis in malignant cells. By characterizing these interactions, the study provides a blueprint for modulating the mitochondrial network through precise molecular interference. The project further explored how these peptides influence the expression of cytoskeletal components and the catalytic activity of metabolic enzymes.

Main Methods:

The experimental design utilized a high-density peptide array consisting of 768 unique sequences synthesized from 19 established VDAC1-interacting partners. Investigators focused their validation efforts on specific motifs derived from Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH), gelsolin, and actin. These selected sequences were synthesized as Cell-Penetrating Peptides (CPPs) to facilitate efficient entry into the intracellular environment. Binding affinity was confirmed through direct interaction assays using purified Voltage-Dependent Anion Channel-1 (VDAC1) protein preparations. Cellular responses were monitored by measuring intracellular Calcium (Ca2+) concentrations and Reactive Oxygen Species (ROS) levels following peptide administration. The researchers also assessed changes in protein expression and oligomerization states using biochemical blotting and microscopic imaging of cytoskeletal architecture. Statistical frameworks were applied to evaluate the significance of the observed changes in transcription factor levels and cell viability.

Main Results:

Synthetic peptides derived from GAPDH, gelsolin, and actin successfully bound to the Voltage-Dependent Anion Channel-1 (VDAC1) and triggered robust apoptotic responses. Treatment with these cell-penetrating sequences resulted in significant elevations of intracellular Calcium (Ca2+) and Reactive Oxygen Species (ROS) within the target cells. Despite their diverse origins, the peptides consistently upregulated the transcription factors p53 and c-Jun while promoting the oligomerization of the mitochondrial channel. The GAPDH-derived fragment induced cell death without altering the catalytic activity of the native enzyme, suggesting a mechanism independent of the glycolytic pathway. Gelsolin-based peptides significantly modified the cytoskeleton by increasing the formation of filopodia and focal adhesions. Peptides based on actin sequences effectively reduced the endogenous expression levels of actin, gelsolin, and tubulin. These multifaceted effects demonstrate that the derived peptides can replicate and even amplify the regulatory functions of their parent proteins.

Conclusions:

The identification of specific binding domains across 19 different partners establishes a comprehensive map of the Voltage-Dependent Anion Channel-1 (VDAC1) regulatory network. These findings suggest that targeting mitochondrial protein-protein interactions with synthetic fragments represents a viable strategy for controlling cell fate. The ability of these sequences to modulate calcium signaling and oxidative stress highlights their potential as multifaceted pharmacological tools. Future therapeutic developments may leverage these cell-penetrating motifs to bypass traditional pathway inhibitors and directly activate the apoptotic machinery. The study confirms that the regulatory role of this mitochondrial pore extends far beyond simple metabolite transport. This research provides a foundational framework for the design of novel drugs aimed at disrupting the VDAC1 interactome in various disease states. The results underscore the importance of this mitochondrial hub for integrating organelle function with broader cellular signaling pathways.

Frequently Asked Questions

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.3K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
8.1K
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside...
13.7K
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
14.1K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.3K
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized...
4.9K